Scientists turn plastic waste into Parkinson’s drug levodopa using engineered bacteria
A novel engineered microbial system transforms discarded plastic into a frontline Parkinson’s treatment, offering a glimpse into a…
SonoPIN technology boosts intracellular delivery of large cancer drugs
Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer…
Defining the limits of immunotherapy in early small-cell lung cancer
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer…
Ozempic Maker Sued After Woman Died From Stomach Paralysis
The maker of Ozempic, Novo Nordisk, has been hit with a lawsuit over allegations of wrongful death after…
FDA telehealth crackdown highlights role of national doctor networks
The Food and Drug Administration is cracking down on telehealth companies’ marketing of compounded versions of weight loss…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
Battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role
You’ve heard of the little blue pill. Now, a new documentary is turning the spotlight on the pink…
TrumpRx: High expectations, but limited impact a month after launch
WASHINGTON — President Trump heralded his signature drug discount platform, TrumpRx, as “one of the most transformative health…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
Distressed chemical makers get relief; carbon capture MOF company raises funds
It’s more than a year into Donald J. Trump’s second term, and business leaders have no more certainty…